Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Dermatofibroma natural history, complications and prognosis
Introduction
Overview
Overview
Dermatofibroma usually develops in the third decade of life, and most of them are asymptomatic. Common complications of dermatofibroma are related to excisional removing of the lesion and include, bleeding, infection and scar. Prognosis is generally excellent. Although, in very rare cases metastases are seen.
Natural History, Complications, and Prognosis
Natural History, Complications, and Prognosis
Natural History
- Dermatofibroma usually develops in the third decade of life, and most of them are asymptomatic.[1][2][3]
Complications
- Common complications of dermatofibroma are related to excisional removing of the lesion and include:[4]
Prognosis
- Prognosis is generally excellent. Although, in very rare cases metastases are seen.[5]
References
References
- ↑ Agarwal, Atin; Gopinath, Arun; Tetzlaff, Michael T.; Prieto, Victor G. (2017). “Phosphohistone-H3 and Ki67”. The American Journal of Dermatopathology. 39 (7): 504–507. doi:10.1097/DAD.0000000000000690. ISSN 0193-1091.
- ↑ Buehler, Darya; Weisman, Paul (2017). “Soft Tissue Tumors of Uncertain Histogenesis”. Clinics in Laboratory Medicine. 37 (3): 647–671. doi:10.1016/j.cll.2017.06.005. ISSN 0272-2712.
- ↑ Han, Tae Young; Chang, Hee Sun; Lee, June Hyun Kyung; Lee, Won-Mi; Son, Sook-Ja (2011). “A Clinical and Histopathological Study of 122 Cases of Dermatofibroma (Benign Fibrous Histiocytoma)”. Annals of Dermatology. 23 (2): 185. doi:10.5021/ad.2011.23.2.185. ISSN 1013-9087.
- ↑ David J.. Myers & Eric P.. Fillman (2019). “Dermatofibroma”. PMID 29262213.
- ↑ Romano, Ryan C.; Fritchie, Karen J. (2017). “Fibrohistiocytic Tumors”. Clinics in Laboratory Medicine. 37 (3): 603–631. doi:10.1016/j.cll.2017.05.007. ISSN 0272-2712.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]